INDIA STOCKS-India equity benchmarks to open flat; pharma in focus after US tariffs on branded drugs
Sept 26 (Reuters) - India's equity benchmarks are likely to open little changed on Friday, but the sentiment will be one of caution as tariff worries resurfaced after U.S. President Donald Trump announced a 100% levy on branded drugs and 25% on heavy-duty trucks.
Gift Nifty futures GIFc1 were trading at 24,939 points as of 07:46 a.m. IST, indicating that the benchmark Nifty 50 .NSEI will open near Thursday's close of 24,890.85.
Trump on Thursday unleashed a fresh round of punishing tariffs on a broad range of imported goods, including branded and patented drugs, and heavy-duty trucks, effective October 1.
The U.S. accounts for slightly more than a third of India's pharmaceutical exports, which comprise mainly cheaper generic versions of popular drugs. Exports to the country rose 20% to about $10.5 billion in fiscal 2025.
"It needs to be seen whether there will be an exception for critical and chronic drugs," said Kranthi Bathini, director of equity strategy at WealthMills Securities, adding that the fresh tariffs would affect the pharma stocks in the "short- to medium-term".
Indian equities have been under pressure due to tariffs, with Trump's crackdown on H-1B visas - which could raise costs for information technology companies - compounding the sell-off.
Foreign portfolio investors have sold more than $17 billion worth of Indian shares so far in 2025, as per securities depository data, including Thursday's 49.95 billion rupees ($562.69 million) worth of sales.
The benchmark Nifty 50 and Sensex .BSESN have fallen more than 2% each in the last five sessions, marking their longest losing run in six months.
STOCKS TO WATCH
** Tata Motors TAMO.NS British-arm Jaguar Land Rover says some of its digital systems were back online following a recent cyber attack that has crippled its operations
** U.S. customs officials investigating whether solar company Waaree Energies WAAN.NS sidestepped U.S. tariffs on Chinese-made cells and panels by labeling them as made in India
** Rites Ltd RITS.NS receives $18 million worth of order from Talis Logistics, South Africa for supply and commissioning of locomotives
($1 = 88.7700 Indian rupees)
Related Articles
Alibaba – the Poster child of the Chinese AI Revolution
TradingKey - In the beginning of the year, Alibaba ADR at the New York Stock Exchange was traded at $84.95. AS of September 25th, the price is already $176.44, or more than double – a remarkable rally that doubled the price within less than ten months.
Carnival’s Q3 2025 Earnings Preview: Can Strong Demand and Celebration Key Drive Valuation Higher?
TradingKey - Fueled by robust consumer demand for cruise travel, Carnival has hit all-time highs in several key metrics, including revenue, yield, and customer deposits. Its stock has performed strongly in 2025, with a year-to-date gain exceeding 20% and a nearly 70% increase over the past 12 months
U.S. August PCE Preview: Four-Run PCE Bounce Challenges the Fed’s Three-Cut Plan
TradingKey - The U.S. Bureau of Economic Analysis (BEA) will release the August Personal Consumption Expenditures (PCE) Price Index on Friday, September 26, with markets closely watching how much tariff pass-through effects have influenced inflation.
U.S. August PCE: Inflation Remains the Market's Greatest Risk
Our baseline forecast anticipates sustained asset price increases. However, if inflation surpasses market expectations in the coming months, it could hinder further rate cuts and pose the greatest risk to financial markets.
Memory Giant Micron Delivers Stellar Q4 FY2025 with Explosive DRAM and HBM Growth
TradingKey - Micron Technology, Inc. (NASDAQ: MU) delivered a stellar Q4 FY2025 earnings report, exceeding expectations on revenue, earnings, and margins. The company reported total revenue of $11.32 billion, up 46% YoY and 22% sequentially, surpassing the consensus forecast of $11.1 billion.
